Add BrightSurf on Google Email

Science News for November 8, 2025


Single-cell insights reveal how HPV status reshapes penile tumor immunity

Researchers analyzed 52,980 single cells from 11 patients with HPV-positive penile cancer, revealing distinct immune remodeling associated with viral status. HPV-positive tumors contained fewer proliferative macrophages and less exhausted CD8+ T cells, along with stronger chemokine signaling.

SourceWest China Hospital of Sichuan University·JournalPrecision Clinical Medicine·DateNov 8, 2025

Recovery strategies, mismatches and consequences identified in government-led food supply chain during COVID-19 simulation

This study identified key challenges in government-led food supply chains during the pandemic, including transportation disruptions and production-demand mismatches. Effective recovery strategies include enhancing transportation capacity, establishing new district warehouses, and increasing production capacity.

SourceHigher Education Press·JournalFrontiers of Engineering Management·TypeExperimental study·DateNov 8, 2025
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Visualizing blockchain in construction projects: Status quo, challenges, and a guideline for implementation

This study aims to visualize blockchain-based data management processes in construction projects to gain trust in the system. The research identifies current patterns and challenges of DMP visualization on blockchain systems and develops guidelines for visualizing these processes according to construction project needs.

SourceHigher Education Press·JournalFrontiers of Engineering Management·TypeExperimental study·DateNov 8, 2025
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke

In a clinical trial of 12,257 patients at high risk, investigators found that adding the drug evolocumab to a patient’s treatment reduced the risk of a first heart attack, first stroke, or coronary heart disease death by 25%. The study also showed a 36% reduction in heart attacks and a nominally lower rate of death in the evolocumab arm.

SourceMass General Brigham·JournalNew England Journal of Medicine·DateNov 8, 2025
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers

Steatotic liver disease, caused by metabolic dysfunction-associated steatosis, alcohol-related liver disease, and more, affects over 30% of adults worldwide. Emerging genetic variants like PNPLA3, TM6SF2, and MBOAT7 modulate susceptibility to SLD, which progresses to cancer through cumulative genomic instability and immune dysregulation.

SourceFirst Hospital of Jilin University·JournaleGastroenterology·DateNov 8, 2025